Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse‐free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia

BACKGROUND: The Philadelphia chromosome is associated with a poor prognosis in acute lymphoblastic leukemia (ALL). While hematopoietic stem cell transplantation (HSCT) has been regarded as a favorable treatment option in adult Philadelphia‐positive (Ph+) ALL, its benefit is less clear in the era of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jeremy, Douer, Dan, Aldoss, Ibrahim, Vahdani, Golnaz, Jeong, Ah‐Reum, Ghaznavi, Zunera, Zhang, Sherry, Yaghmour, George, Lee, Kum‐Ja, Weissman, Ashley, Akhtari, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558592/
https://www.ncbi.nlm.nih.gov/pubmed/31016870
http://dx.doi.org/10.1002/cam4.2153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558592/
https://www.ncbi.nlm.nih.gov/pubmed/31016870
http://dx.doi.org/10.1002/cam4.2153

Ejemplares similares